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SignalingKSHV effectively binds, enters and establishes infection in THP-1 cells with initial concurrent expression of
latent ORF73 and lytic ORF50 genes and subsequent persistence of ORF73. KSHV genome persisted for
30 days and lytic cycle could be activated. KSHV utilized heparan sulfate for binding to THP-1 cells and
primary monocytes. Blocking DC-SIGN did not inhibit KSHV binding; however, virus entry in THP-1 cells and
in primary monocytes was reduced. In addition to the previously identiﬁed integrins α3β1, αvβ3 and αvβ5,
integrin α5β1 was also utilized for infection. KSHV entered THP-1 cells via clathrin and caveolin mediated
endocytosis and did not utilize macropinocytosis as in human dermal endothelial cells, and required an
endosomal acidiﬁcation. Infection also induced phosphorylation of FAK, Src, PI3K, NF-κB and ERK1/2
signaling molecules, and entry was blocked by tyrosine kinase inhibitors. These ﬁndings suggest that THP-1
cells are highly useful model for studying KSHV infection of monocytes.(B. Chandran).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Kaposi's sarcoma associated herpesvirus (KSHV/HHV8), a γ2-
herpesvirus, is etiologically linked with Kaposi sarcoma (KS) and with
two lymphoproliferative disorders, primary effusion lymphoma (PEL)
and some forms of multicentric Castleman's disease (MCD). KS is a
reactive angioproliferative chronic inﬂammation associated lesion
that is characterized by latently infected spindle cells of endothelial
origin, ﬁbroblasts and inﬁltrating inﬂammatory cells including
monocytes (Ganem, 2006). The microenvironment of KS is rich in
several growth factors, chemokines and inﬂammatory cytokines
which are implicated in the pathogenesis of KS (Douglas et al., 2007).
In vivo, KSHV DNA and transcripts have been detected in a variety
of cells which include B cells from peripheral blood, B cells of PEL and
MCD lesions, ﬂat endothelial cells lining the vascular spaces of KS
lesions, typical KS spindle cells, CD45+/CD68+ monocytes in KS
lesions, keratinocytes, and epithelial cells (Ganem, 1997; Mocarski,
1997). KSHV DNA is present in a latent form in the vascular
endothelial and spindle cells of KS tissues and expression of latency
associated LANA-1 (ORF 73), v-cyclin D (ORF 72), v-FLIP (K13) and
Kaposin (K12) genes have been demonstrated in these cells
(Dourmishev et al., 2003; Ganem, 1997; Schulz et al., 2002; Staskuset al., 1997; Zhong et al., 1996). Lytic infection is also detected in KS
lesions with b1% of inﬁltrating inﬂammatory monocytic cells positive
for lytic cycle proteins (Dourmishev et al., 2003; Ganem, 1997).
Detailed analyses of KSHV infection of various in vitro target cells
are essential to fully understand the tropism and pathogenesis of
KSHV. KSHV infects a variety of target cells in vitro such as human B
cells, monocytes, endothelial, epithelial and ﬁbroblast cells as well as
several animal cells such as BHK-21 cells, monkey kidney cells, CHO
cells, and primary embryonic mouse ﬁbroblast cells (Akula et al.,
2001a,b, 2002; Ganem, 1998; Naranatt et al., 2003; Schulz et al.,
2002). However, unlike α and β-herpesviruses, de novo infection of
adherent target cells by KSHV does not lead to a productive lytic cycle.
Instead, KSHV enters into latency and expresses only a few genes from
non-integrated circular episome in the infected cell nucleus. KSHV in
vitro infection of human microvascular dermal endothelial cells
(HMVEC-d), human foreskin ﬁbroblast cells (HFF), human umbilical
vein endothelial cells (HUVEC) and human embryonic kidney
epithelial cells (293) is characterized by the persistent expression of
latent ORF72, ORF73, and K13 genes that is concurrent with the
transient expression of a limited number of lytic genes with anti-
apoptotic and immune modulation functions, including the lytic cycle
switch protein Rta/ORF50, early lytic K8, v-IRF-2, K5, ORF59, ORF8 and
late lytic gpK8.1A/B (Krishnan et al., 2004; Lan et al., 2005; Raghu et
al., 2009). In HMVEC-d, HFF and 293 cells, expression of latent genes
continues while lytic gene expression, except K5, decreases rapidly by
24 h post-infection (p.i.) (Bechtel et al., 2003; Krishnan et al., 2004).
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target cells to establishment of viral gene expression. These events
could be sequentially categorized into six overlapping indiscrete
dynamic phases. Phase 1 involves binding to target cells via various
receptors overlapping with signal induction (phase 2) followed by
virus internalization into host cells (phase 3). In phase 4, viral capsid/
tegument trafﬁcs through the cytoplasm and in phase 5, viral DNA
enters into the nucleus. Phase 6 involves the expression of viral and
host genes. Previously, we have extensively characterized the various
stages of de novo KSHV infection of adherent target cells such as
HMVEC-d, HUVEC and HFF cells with a focus on receptors, mode of
viral entry, viral gene expression and induction of preexisting host cell
signaling cascade (Akula et al., 2001a,b, 2002; Krishnan et al., 2004;
Naranatt et al., 2002, 2003, 2004, 2005; Raghu et al., 2007, 2009;
Sharma-Walia et al., 2005; Veettil et al., 2006, 2008).
KSHV's broad in vitro cellular tropism may be in part due to its
interactions with the ubiquitous cell surface heparan sulfate (HS)
proteoglycan (Akula et al., 2001a,b) which is similar to several other
herpesviruses. Our studies demonstrate that α3β1, αVβ3, and αVβ5
integrins play important roles in KSHV infection of adherent target
cells, such as HMVEC-d, HFF and 293 cells, including entry and
induction of host–signal pathways to facilitate viral infection (Akula et
al., 2001a,b, 2002; Naranatt et al., 2002, 2003, 2004, 2005; Raghu et al.,
2007, 2009; Sharma-Walia et al., 2005; Veettil et al., 2006, 2008).
Two studies reported that dendritic cell-speciﬁc intercellular
adhesion molecule-3 (ICAM-3) grabbing non-integrin (DC-SIGN;Fig. 1. A and B: KSHV binding assays. THP-1 cells (1×106) left uninfected (UI) or were incub
(A) or with 50 μl of labeled KSHV for indicated time points (B). The cells were washed, lys
minute (cpm) were determined. Each reaction was done in duplicate, and each point represe
KSHVwere pretreated with heparin (100 μg/ml) for 1 h and then incubated with the target c
incubated with different DNA copies per cell. Two hours p.i., unbound and uninternalized
infected with 10 KSHV DNA copies per cell and at different time points and uninternalized
numbers were determined by real-time DNA PCR with TaqMan probe and primers speciﬁ
generated by using known concentrations of the cloned ORF73 gene. Percent internalization
as 100%. Each time point represents the average±SD of three experiments.CD209) plays a role in infection of human myeloid dendritic cells
(DCs), macrophages and activated B cells (Rappocciolo et al., 2006,
2008). KSHV binding and infection were blocked by anti-DC-SIGN
monoclonal antibody, mannan (a ligand for DC-SIGN), and by soluble
DC-SIGN. However, pretreatment of cells with anti-DC-SIGN antibodies
did not completely block KSHV binding and infection. This could be due
to binding to HS and integrins which were not tested in these studies.
Though KSHV has been detected in several cells types including
spindle cells of endothelial origin, ﬁbroblasts and inﬁltrating
inﬂammatory cells, KSHV de novo infection of targets cells other
than HMVEC-d, HUVEC and HFF cells has not been studied in detail.
Primary B cells from normal individuals are relatively resistant to in
vitro infection with KSHV perhaps due to the lack of HS in these cells
(Jarousse et al., 2008) and infection does not result in immortalization
as with γ1-Epstein–Barr virus (EBV). In contrast, activated blood and
tonsil B cells were productively infected with KSHV which was shown
by the increase in viral DNA, expression of viral lytic and latency
proteins, and the production of infectious virus (Rappocciolo et al.,
2008). A limited amount of cell death was observed in the infected B-
cell cultures compared to that of uninfected cell cultures, suggesting
that infectious virus production and subsequent destruction of the cell
were restricted to a portion of the activated B cells (Rappocciolo et al.,
2008). In contrast, as in endothelial and ﬁbroblast cells, DC and
macrophages supported the expression of only a limited number of
KSHV lytic genes early after virus entry with little or no production of
infectious virus (Rappocciolo et al., 2006).ated with an increasing amount of [3H]thymidine-labeled puriﬁed KSHV for 1 h at 4 °C
ed, and precipitated with trichloroacetic acid, and the cell-associated virus counts per
nts the average±SD of three experiments. As speciﬁcity control, [3H]thymidine-labeled
ells for 1 h at 4 °C. C and D: KSHV entry into THP-1 cells. (C) THP-1 cells (0.5×106) were
viruses were removed by washing and trypsinization. (D) THP-1 cells (1×106) were
viruses removed by washing and trypsinization. For C and D, internalized viral copy
c for ORF73. Viral DNA copy numbers were calculated based on the standard curve
of KSHV was calculated by considering maximum internalized virus DNA copy number
Fig. 2. A. Kinetics of KSHV genome delivery into infected cell nuclei. THP-1 cells
(1×106) were infected with 10 KSHV DNA copies per cell. At different time points,
uninternalized virus was removed by washing and trypsinization. Nuclei were isolated
and purity of the isolated nuclei was determined by the presence of lamin B and
absence of tubulin in Western blots of the isolated nuclei. DNA (100 ng) puriﬁed from
infected cell nuclei was used to determine the number of KSHV DNA copies delivered to
nuclei by real-time DNA PCR for the ORF73 gene as described in the Fig. 1C and D
legend. B and C. Kinetics of KSHV gene expression in THP-1 cells. THP-1 cells (1 × 106)
were infected with 30 KSHV DNA copies per cell. At different time points p.i., RNA was
isolated, treated with DNase I, and 250 ng of DNase-treated RNA was subjected to real-
time RT-PCR with primers and TaqMan probes for the ORF 73 and 50 genes. Known
concentrations of DNase-treated in vitro-transcribed ORF 50 and ORF 73 transcripts
were used to construct a real-time RT-PCR standard curve fromwhich the relative copy
numbers of viral transcripts were determined and normalized to 18s rRNA used as
internal control.
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lesions and are key players in the inﬂammatory response, a crucial
step in the pathogenesis of KS. Themonocytic cell line THP-1 has been
used as a model cell system to deﬁne the potential role of Toll like
receptors (TLR) in KSHV infection(West and Damania, 2008).
However, infections were carried out by mixing virus with polybrene
and by centrifugation (spinoculation) by passing the need for the
receptors. Moreover, RNA was isolated at 16 h post-infection (p.i.) for
demonstrating TLR and KSHV gene expression. LANA mRNA expres-
sion was detected 16 h p.i. and no other viral genes were examined
(West and Damania, 2008). Compared to in vitro culture of monocytes
from human peripheral blood, THP-1 cells are easy to grow. Hence, in
order to expand the use of THP-1 cells as amodel system for dissecting
out KSHV interactions with humanmonocytes here we systematically
examined the various early steps of de novo infection.
Results
KSHV efﬁciently binds to THP-1 cells
The ﬁrst essential event in KSHV infection is binding to the target
cells. KSHV binding to a variety of cells is mediated through the initial
interaction with ubiquitous cell surface HS (Akula et al., 2001a,b, 2003;
Wang et al., 2001). We ﬁrst examined the time kinetics and dose
dependence of virus binding to THP-1 cells using [3H]thymidine-labeled
KSHV (Akula et al., 2001a). Dose dependent virus bindingwas observed
in cells incubated with an increasing amount of labeled KSHV (Fig. 1A).
The kinetics of binding revealed very efﬁcient KSHV binding with about
80% ofmaximumbinding occurring as early as 5 min p.i. which attained
a plateau by 15 min p.i. (Fig. 1B). In both of the above experiments,
pretreatment of virus with heparin abrogated the binding by N90%
suggesting a very signiﬁcant role for HS in KSHV binding to THP-1 cells.
Kinetics of KSHV DNA internalization in THP-1 cells
To deﬁne KSHV entry, THP-1 cells were infected for 2 h with
increasing KSHV DNA copies per cell (5–40) and internalized virus
copy number was determined by real-time DNA PCR for the ORF73 gene
(Krishnan et al., 2004). As expected, KSHV internalization increasedwith
the increasing amount of input virus DNA copy numbers (Fig. 1C).When
kinetics of KSHV internalization into THP-1 cells was examined by
infecting with 10 KSHV DNA copies per cell for different time periods at
37 °C, a signiﬁcant amountof internalizedvirus couldbedetectedas early
as 30 min p.i., which reached a peak at 90 min p.i., plateaued at 120 min
p.i. with a slight decrease at 150 min and 180 min p.i. (Fig. 1D). Together,
these results demonstrated the efﬁcient entry of KSHV in to THP-1 cells.
Kinetics of nuclear entry of KSHV DNA in THP-1 cells
To determine whether the internalized KSHV reach the infected cell
nuclei, THP-1 cells were infected for different time periods at 37 °Cwith
10 KSHV DNA copies per cells, nuclei were isolated, and DNA puriﬁed
from these nuclei was used to determine virus copy number by real-
time DNA PCR (Raghu et al., 2007). KSHV genome could be detected in
the infected cell nuclei as early as 30 min p.i. which increased rapidly
after 60 minp.i. andmaximumviral copynumberswere found at 90and
120 min p.i. (Fig. 2A). These results demonstrated that after entering
THP-1 cells, KSHV delivers its DNA into the nucleus, an essential
prerequisite for KSHV to establish infection in any target cells.
THP-1 cells support expression of latent ORF73 and lytic ORF50 KSHV
genes
KSHV ORF73 encoded LANA-1 plays a role in maintenance of
latency and mediates tethering of viral genome to the host
chromosome in latently infected cells (Verma et al., 2007). KSHVimmediate early lytic switch RTA (ORF 50) protein drives the
transcription of multiple viral genes involved in lytic replication.
Since expression of both these genes plays vital roles in the KSHV life
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infected THP-1 cells. As early as 2 h p.i., signiﬁcant levels of both
ORF73 and ORF50 messages were detected (Fig. 2B and C). ORF73
messages increased steadily and reached peak by 24 h and sustained
levels were observed at 48 h p.i. We also observed a robust ORF50
expression at 2 h p.i. that steadily increased reaching a peak at 24–
48 h p.i. (Fig. 2C). To support the gene expression ﬁndings, we
examined the expression of LANA-1 protein and late lytic marker
envelope glycoprotein gpK8.1A by IFA. A signiﬁcant number of LANA-
1 (26% at 48 h p.i.) and gpK8.1A (30% at 48 h p.i.) positive cells were
observed at all time points from 8 h to 48 h p.i. (Fig. 3A and B). These
results clearly demonstrated that human monocytic THP-1 cells are
susceptible to primary KSHV infection and support concurrent
expression of latent and lytic KSHV genes.Fig. 3. A and B: Immunoﬂuorescence analysis of LANA-1 and gpK8.1A expression. THP-1 cells
removed by washing and trypsinization. Infected and uninfected cells were further incubate
Triton X-100 for 5 min and blocked with Image-iT™ FX signal enhancer. Cells were stained
(A) and gpK8.1A (B) were visualized by incubation with Alexa-488 (green) and Alexa 594 (r
DAPI (blue). The white arrows point at the expression of LANA-1 and gpK8.1A in infected cell
DNA copies per cell) for 2 h p.i., were washed, trypsinized and incubated for 1, 2, 3, 4, 5, 15,
determined by real-time DNA PCR for ORF73 as per legend in Fig. 1C and D. Each bar represe
normalizing with total DNA from each sample. D and E. KSHV lytic reactivation in infected
washing and trypsinization and infected cells were cultured for 21 days in complete media.
5 days. KSHV lytic reactivation was assessed in cell culture supernatant (D) and in cells (E) b
1C and D. The values represent the fold increase in KSHV genome copy number in TPA treaKSHV establishes persistent infection in THP-1 cells
KSHV positive PEL derived B-cell lines maintain multiple copies of
KSHV genome indeﬁnitely. In contrast, endothelial cells derived from
KS spindle cells, as well as de novo infected endothelial cells, rapidly
loose the KSHV episome (Bechtel et al., 2003). To determine whether
the KSHV genome persists in THP-1 cells we examined the presence of
viral genome in infected THP-1 cells from 1 through 30 days p.i.
THP-1 cells (1×106) infected with 10 KSHV DNA copies per cell for
2 hwerewashed, trypsinized to remove uninternalized virus and then
incubated at 37 °C. At different days p.i., DNA was isolated from the
cell pellet and KSHV genome copy number persisting in the cells was
determined by real-time RT-PCR for the ORF73 gene. Persistent KSHV
genome copy number was represented as genome copies per 1×106were infected with 30 KSHV DNA copies per cell for 2 h and uninternalized viruses were
d at 37 °C, washed, ﬁxed in 2% paraformaldehyde for 10 min, permeabilized with 0.2%
with LANA and gpK8.1A antibodies and visualized by ﬂuorescence microscopy. LANA-1
ed) secondary antibodies, respectively, and cell nuclei were visualized by staining with
s. C. Detection of persistent KSHV infection. THP-1 cells (1×106) infected with KSHV (10
25 and 30 days in complete medium. KSHV copy number persisting in THP-1 cells was
nts the number of KSHV genomes per 1×106 THP-1 cells; the values were derived upon
THP-1 cells. THP-1 cells infected with KSHV for 2 h, uninternalized viruses removed by
At 21 days p.i. these cells were either left untreated or treated with TPA (20 ng/ml) for
y determining the viral genome copy number by real-time DNA PCR as per legend in Fig.
ted cells compared untreated cells.
Fig. 4. A. KSHV binding in the presence of heparin. THP-1 cells (1×106) were incubated
with heparin (25 μg to 150 μg/ml) pretreated [3H]thymidine-labeled KSHV or
untreated labeled KSHV at 4 °C for 1 h. The cell-associated virus was quantiﬁed as
described under the Fig. 1A and B legend. Each reaction was done in duplicate, and each
point represents the average±SD of three experiments. The cell-bound virus in the
presence of heparin was expressed as the percentage of virus binding compared to that
of untreated THP-1 cells. B. KSHV binding in presence of chondroitin sulfate and in
heparinase treated THP-1 cells. Chondroitin sulfate pretreated or untreated KSHV were
incubated with 1×106 THP-1 cells (ﬁxed with 0.1% paraformaldehyde) at 4 °C for 1 h or
heparinase I and III treated (5 and 10 units/ml, for 2 h at 37 °C). THP-1 cells weremildly
ﬁxed with 0.1% paraformaldehyde and incubated with KSHV 4 °C for 1 h. The unbound
viruses were removed by washing. The cell-bound virus was quantiﬁed by real-time
DNA PCR as described in the Fig. 1C and D legend. Each point represents the average
±SD of three experiments. The cell-bound virus in the presence of chondroitin sulfate
or in the heparinase treated THP-1 was expressed as the percentage of virus binding
compared to that of untreated controls. C. KSHV binding in the presence of mannan.
THP-1 cells (1×106) mock treated or pre-incubated with the indicated concentrations
of mannan at 4 °C for 1 h. The cell-associated virus was quantiﬁed as described under
the Fig. 1A and B legend. Each reaction was done in duplicate, and each point represents
the average±SD of three experiments. The cell-bound virus in the presence of mannan
was expressed as the percentage of virus binding compared to that of untreated THP-1
cells.
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reasoned that persistent KSHV genome copy numbers will appear to
decrease drastically and hence the estimated viral DNA copy numbers
will be probably an under representation of persistence. To overcome
this problem and to compensate for the replication of uninfected cells,
the copy numbers represented in Fig. 3C were derived by normalizing
the copy numbers to total DNA yield from the cell pellet. As seen in
endothelial cells (Grundhoff and Ganem, 2004), THP-1 cells also lost
KSHV genome over time. However, a signiﬁcant number of KSHV
genome copies could be detected after 5 and 30 days p.i. Compared to
1 day p.i., as much as 54% and 34% of KSHV genome copy numbers
were detected at 5 and 30 days p.i., respectively (Fig. 3C). Taken
together, these results suggest that the KSHV genome is maintained in
the infected THP-1 cells and genome copy numbers decrease over
time.
Wenext examinedwhether latentKSHV in THP-1 cells canundergo
lytic reactivation to produce progeny virus. Infected THP-1 cells at
21 days p.i. were left untreated or treated with TPA (20 ng/ml). The
cell culture supernatants and cells were harvested after 5 days of TPA
treatment and KSHV genome copy numbers were determined in by
real-time DNA PCR. Compared to uninduced THP-1 cells 2.5- and 3-
fold increase in KSHV genome copy numbers were observed in TPA
induced supernatant and cells, respectively (Fig. 3D and E). Overall,
these observations suggested that similar to BCBL1 cells, TPA could
induce KSHV lytic reactivation in the infected THP-1 cells.
KSHV binding in THP-1 cells involves initial interaction with HS
Like many α, β and γ2 herpesviruses, initial biding of KSHV to
adherent target cells involves interaction with HS moieties (Akula et
al., 2001a). To determine whether KSHV interaction with THP-1 cells
also involves HS molecules, the ability of soluble heparin to inhibit
KSHV binding to THP-1 cells was examined. A KSHV binding assaywas
carried out using heparin pretreated [3H]thymidine-labeled KSHV as
described before (Akula et al., 2001b). KSHV binding was inhibited by
more than 80% at heparin concentrations as low as 25 μg/ml and
similar levels of KSHV binding inhibition was observed even at higher
concentrations of heparin pretreatment (Fig. 4A). Furthermore
enzymatic removal of cell surface HS with heparinase I and III
signiﬁcantly reduced the KSHV binding by 40–60% (Fig. 4B). However,
pre-incubation of KSHV with chondroitin sulfate did not inhibit the
KSHV binding suggesting cell surface chondroitin sulfate glycosami-
noglycans do not play role in KSHV binding to THP-1 cells (Fig. 4B).
These results suggest KSHV infection of THP-1 cells involves initial
binding interactions with cell surface HS moieties.
DC-SIGN does not play a role in KSHV binding to THP-1 cells
Recent studies by Rappocciolo et al. (2006, 2008) suggested a role
for DC-SIGN in KSHV binding and entry in human macrophages,
dendritic cells and activated B cells. Since THP-1 cells originated from
myeloid lineage with about 71% of cells expressing DC-SIGN (Fig. S1)
the role of DC-SIGN in KSHV binding was examined. THP-1 cells were
pre-incubated with various concentrations of mannan, a ligand for
DC-SIGN, and radiolabeled KSHV binding was determined. Mannan
did not inhibit KSHV binding signiﬁcantly, even at concentrations up
to 400 μg/ml. This suggests an insigniﬁcant role for DC-SIGN in KSHV
binding to THP-1 cells (Fig. 4C).
Heparan sulfate and DC-SIGN play roles in KSHV entry in THP-1 cells
We next examined whether HS and DC-SIGN play roles in KSHV
internalization. HS and DC-SIGN were blocked by heparin and
mannan, respectively. As expected from the binding results
(Fig. 4A), heparin blocked KSHV internalization by more than 80%
(Fig. 5A). In contrast, KSHV internalization was inhibited by mannanonly at very high concentrations (400 and 500 μg/ml), and then only
to a maximum of about 60% inhibition (Fig. 5A). In a parallel
experiment where heparin (100 μg/ml) and mannan (300 μg/ml)
were used together to block both HS and DC-SIGN, we did not observe
Fig. 5. A. KSHV internalization in the presence of heparin and mannan. THP-1 cells
(1×106) mock treated or pre-incubated with the indicated concentrations of mannan
at 4 °C were infected with 10 KSHV DNA copies per cell or heparin pretreated KSHV
(100 μg/ml). At different time points, uninternalized virus was removed by washing
and trypsinization. Infected and mock infected cells were washed and internalized viral
copy numbers were determined by real-time DNA PCR as described in the Fig. 1C/D
legend. The data are represented as the percent inhibition of KSHV DNA internalized in
comparison with cells incubated with virus alone. Each reaction was done in duplicate
and each bar represents the mean±SD of the results of three experiments. B. KSHV
internalization in THP-1 cells upon blocking DC-SIGN. THP-1 cells incubated with
mouse IgG or mouse anti-DC-SIGNmAb at 4 °C for 1 h. The washed cells were incubated
with KSHV (10 genome copies/cell) at 4 °C for 1 h followed by at 37 °C for 1 h.
Uninternalized virus was removed by washing and trypsinization, internalized viral
copy numbers were determined by real-time DNA PCR as described in the Fig. 1C/D
legend. The data are represented as the percent inhibition of KSHV DNA internalization
in comparison with IgG control. C. KSHV gene expression in the presence of soluble
integrins. THP-1 cells (1×106) were infected with 30 KSHV DNA copies per cell of
untreated virus or with virus pretreated with 10 μg/ml of soluble α3β1, αvβ3, αvβ5,
α5β1 and α4β7 integrins for 1 h at 37 °C. At 2 h p.i. uninternalized virus was removed
bywashing and trypsinization and the infected cells were further incubated. At 24 h p.i.,
the cells were washed, RNA was isolated, ORF73 gene expression was examined as
described under the Fig. 2B legend. ORF73 gene expression was represented as percent
inhibition compared to control untreated KSHV infection.
108 N. Kerur et al. / Virology 406 (2010) 103–116any signiﬁcant synergetic/additive inhibition (Fig. 5A). Although the
inhibition was greater than with mannan alone the values did not
vary signiﬁcantly from the inhibition by heparin alone.
We next examined whether KSHV entry in THP-1 cells could be
inhibited by blocking with anti-DC-SIGN antibody. As shown the
Fig. 5B, blocking of DC-SIGN with mouse anti-DC-SIGN mAb inhibited
the KSHV internalization by 43%. In contrast, no inhibition was
observed in IgG incubated control THP-1 cells. Taken together our
observations suggest that KSHV uses DC-SIGN as one of the receptor
for internalization in THP-1 cells.
KSHV–integrin interactions play roles in KSHV infection of THP-1 cells
KSHV utilizes α3β1, αvβ3, αvβ5 integrins for HMVEC-d, HFF and
293 cell infection (Veettil et al., 2008). To determine whether integrins
play a role in KSHV infection of THP-1 cells, cells were infected with
KSHV which had been pre-incubated with 10 μg/ml of commercially
availablehumansoluble integrinsα3β1,αvβ3,αvβ5,α5β1andα4β7at
37 °C for 1 h and viral gene expressionwas examined at 24 hp.i. by real-
timeRT-PCR. As shown in Fig. 5C, integrinsα3β1,αvβ3,αvβ5 andα5β1
inhibited ORF73 expression signiﬁcantly albeit at varying degrees.
Soluble integrin α3β1 exhibited maximal inhibition in ORF73 expres-
sion (94%) followed byαvβ5 (83%),α5β1(82%) andαvβ3 (68%).When
we used soluble integrin α4β7, that is also present in THP-1 cells as
speciﬁcity control, we did not observe any inhibition of KSHV gene
expression. Heparin pretreatment of virus inhibited gene expression by
90% (Fig. 5C). Soluble integrins did not block virus binding (data not
shown) and these ﬁndings suggest that KSHV interactions with
integrins α3β1, αvβ3, αvβ5 and α5β1 are crucial for the post-HS
binding stage of establishing infection in THP-1 target cells.
To further demonstrate the physical association between KSHV
and the integrins, THP-1 cells infected with KSHV for 1, 5 and 10 min
were examined by confocal microscopy for co-localization of virus
with integrins. As it can be seen in Fig. 6A to D, KSHV co-localized with
all four integrins. Speciﬁcity of these interactions is shown by non-
reactivity with αvβ6, an abundant THP-1 cell integrin (Fig. 6E). Taken
together, these studies suggest that multiple integrins, such as α3β1,
αvβ3, αvβ5 and α5β1, play a signiﬁcant role in KSHV infection of
THP-1 cells.
KSHV induces the FAK, Src, PI3K, NF-κB and ERK1/2 signal molecules
early during infection of THP-1 cells
Our earlier studies have shown that KSHV, like other viruses,
utilizes interactions with multiple integrins and cellular receptors to
modulate preexisting signaling cascades to facilitate target cell
infection (Graham et al., 2005; Greber, 2002; Marsh and Helenius,
2006; Tufaro, 1997; Veettil et al., 2008). Here we have examined the
induction of signaling cascades in KSHV infected THP-1 cells. THP-1
cells were serum starved for 24 h, infected with KSHV (20 DNA copies
per cell) and signal induction was examined byWestern blotting with
phospho-speciﬁc antibodies.
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that
resides at the sites of integrin clustering, known as focal adhesions (FA).
KSHV infection of THP-1 cells rapidly induced FAK phosphorylation as
early as1 minp.i., and sustaineduntil 15 minp.i. (~1.5-fold) followedby
a drop in activation levels (~1.3-fold) to control cells (Fig. 7A). HS
pretreated KSHV failed to induce FAK phosphorylation demonstrating
the speciﬁcity of FAK induction and suggested that binding of KSHV to
target cells induces FAK activation. Since KSHV infection of THP-1
induced robust FAK activation, we next examined the downstream Src
activity upon infection of these cells. As seen in Fig. 7B, KSHV infection
induced rapid and robust Src activation of 4.1-fold at 1 min p.i. which
was sustained at a higher level even at 30 min p.i.
Phosphatidylinositol 3-kinase (PI3K) family of heterodimeric lipid
kinases control activity and subcellular localization of several signal
Fig. 6. Immunoﬂuorescence analysis of KSHV association with integrins. THP-1 cells were infected with 10 KSHV DNA copies per cell for 5 and 10 min. The cells were ﬁxed in 2%
paraformaldehyde for 10 min, permeabilized with 0.2% Triton X-100 for 5 min and blocked. Infected and uninfected cells were stained with anti-KSHV gB and anti-α3β1/αvβ3/
αvβ5/α5β1/αvβ6 integrin antibodies and visualized by confocal microscopy. KSHV-gB and integrins were visualized by incubation with Alexa-488 secondary antibody (green) and
Alexa-594 secondary antibody (red), respectively. The arrows indicate the areas of KSHV co-localization with integrins. A. KSHV+α3β1. B. KSHV+αvβ3. C. KSHV+αvβ5. D. KSHV
+α5β1. E. KSHV+αvβ6.
109N. Kerur et al. / Virology 406 (2010) 103–116transduction molecules involved in cell survival, migration, vesicular
trafﬁcking and cytoskeletal organization. Compared to uninfected
control cells KSHV induced a 2.3-, 2.3- and 2.7-fold increase in p85
phosphorylation at 1, 2 and 15 min p.i. respectively, which dropped
back to physiological levels at 30 min p.i. (Fig. 7C). As expected,
heparin pretreated KSHV did not induce PI3K phosphorylation
(Fig. 7C).
Nuclear factor kappa B (NF-κB) is a member of the highly
conserved Rel family of transcription factors integral to promoting
inﬂammation, cell proliferation and survival. Previously we haveshown a sustained induction of NF-κB that plays a critical role in latent
and lytic viral gene expression during de novo infection of HMVEC-d
and HFF cells (Sadagopan et al., 2007). When we examined the
infected THP-1 cells for phosphorylated p65, as seen in Fig. 7D, KSHV
infection induced robust and sustained p65 phosphorylation from
5 min to 4 h p.i.
Extracellular signal-regulated kinase (ERK1/2) is another crucial
signaling molecule belonging to the mitogen-activated protein kinase
(MAPK) super family that can mediate cell proliferation and
apoptosis. Previously we have observed that ERK1/2 induced early
Fig. 7. Signal induction during KSHV de novo infection of THP-1 cells. THP-1 cells, serum
starved for 24 h, were left uninfected or infectedwith KSHV (20DNA copies/cell) for the
indicated time. Proteins prepared (15 μg) from the infected and uninfected THP-1 were
resolved by SDS-PAGE and transferred onto nitrocellulose membranes. Phosphorylated
and total (A) FAK, (B) Src, (C) PI3K, (D) NF-κB and (E) ERK1/2 proteins were detected
with the respective antibodies. The fold induction of phosphorylation was calculated
based on the ratio of phosphorylated/total at each time point and values represent fold
phosphorylation compared uninfected. HS pretreated KSHV (1 h at 37 °C) was used as
control. (F) Effect of tyrphostin and genistein on KSHV internalization. Untreated and
THP-1 cells pre-incubated with tyrphostin and genistein (1 h at 37 °C) were infected
with KSHV. At 2 h p.i., mock treated and treated cells were washed and trypsinized to
remove uninternalized viruses. Internalized KSHV copy number was determined as
described in Fig. 1C/D. The data are represented as the percent inhibition of KSHV DNA
internalization in comparison with untreated THP-1 cells.
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well as for modulating host genes in HMVEC-d and HFF cells (Sharma-
Walia et al., 2005). Here, we observed about 2.4-fold ERK1/2activation as early as 5 min p.i. of THP-1 cells with a peak at 15 min
p.i. (3.2-fold) (Fig. 7E). Taken together, our data demonstrate that
KSHV induces a robust FAK, Src and PI3K response early during de
novo infection and sustained NF-κB and ERK1/2 induction during the
observed 4 h p.i.
Tyrosine kinases play roles in KSHV infection of THP-1 cells
Genistein and tyrphostin are potent inhibitors of protein tyrosine
kinases (PTK) and can block variety cellular signaling events involving
tyrosine phosphorylation. To determine the effect of blocking signal
induction on KSHV infection, THP-1 cells were pre-incubated with
genistein and tyrphostin for 1 h, washed and infected with 10 KSHV
DNA copies/cell for 2 h and internalized KSHV viral DNA was
quantiﬁed by real-time DNA PCR for the ORF73 gene (Krishnan et
al., 2004). Both tyrphostin and genistein inhibited KSHV internaliza-
tion by 40% and 70%, respectively (Fig. 7F). This suggested that cellular
kinase signaling events play critical roles in KSHV entry into THP-1
cells.
KSHV entry into THP-1 cells involves clathrin and caveolin mediated
endocytic pathways
To examine the mode of KSHV entry, THP-1 cells pretreated with
non-toxic concentrations of various endocytosis inhibitors were
infected with KSHV (10 DNA copies /cell) for 2 h and internalized
viral DNA was quantitated. Chlorpromazine, a clathrin-mediated
endocytosis inhibitor, and ﬁlipin, a caveolar pathway inhibitor, blocked
KSHV entry into THP-1 by 51% and 45%, respectively (Fig. 8A).
Cytochalasin D, a cell permeable mycotoxin, inhibits macropinocytosis
by blocking the formation of microﬁlaments and microtubules. EIPA, a
potent inhibitor of Na+/H+exchangers, is also known to inhibit
marcopinocytosis. When THP-1 cells were pre-incubated with the
cytochalasin D and EIPA, no signiﬁcant effect on KSHV entry was
observed (Fig. 8A). In a parallel experiment where chlorpromazine
(1.5 μg/ml) and ﬁlipin (2.5 μg/ml) were used together to block both
clathrin and caveolar endocytic pathways, we observed a signiﬁcantly
higher inhibition (72.3%) in KSHV internalization compared entry
inhibition by chlorpromazine (51%) or ﬁlipin (45%) alone (Fig. 8A).
These results suggested that KSHV utilizes both clathrin and caveolin
mediated endocytic pathways for entry into THP-1 cells while
macropinocytosis does not appear to play a role in THP-1 infection.
NH4Cl is a weak lysomotropic base known to inhibit endosomal
acidiﬁcation and baﬁlomycin A1 a speciﬁc and potent inhibitor of
vacuolar H+ ATPase inhibits endosomal and lysosome acidiﬁcation.
Pre-incubation of THP-1 cells with non-cytotoxic concentration of
NH4Cl (100 mM) and baﬁlomycin A1 (50 nM) results in decreased
ORF73 gene expression by 45% and 67% respectively, suggesting a
requirement for low pH endocytic environment in the infectious
process of THP-1 cells (Fig. 8B).
KSHV infection of primary monocytes involves role of heparan sulfate
and DC-SIGN
Though THP-1 cells are monocytic cell line, these cells might
signiﬁcantly differ from primary monocytes in some characteristics.
Therefore, we next examined whether KSHV infection of THP-1 cells
resembles the infection in primary monocytes. We found that soluble
heparin and heparinase treatment of primary monocytes inhibit the
KSHV binding by 60–80% and 40–53%, respectively (Fig. 8C). In
contrast, soluble chondroitin sulfate did not have any effect on KSHV
binding (Fig. 8C). Furthermore, blocking DC-SIGN with anti-DC-SIGN
mAb inhibited KSHV internalization by 60% (Fig. 8D). Overall these
observations suggest that, similar to THP-1 cells, heparan sulfate play
roles in KSHV binding to primary monocytes and DC-SIGN also play
roles in KSHV entry in primary monocytes.
Fig. 8. A. Effect of endocytosis inhibitors on KSHV infection of THP-1 cells. Mock treated and THP-1 cells pre-incubated with chlorpromazine (Chlor), cytochalasin D (Cyto D), EIPA
and ﬁlipin (1 h at 37 °C) were infected with KSHV. At 2 h p.i., untreated (UT) and treated cells were washed and trypsinized to remove uninternalized viruses and then internalized
KSHV copy number was determined as described in Fig. 1C/D. The data are represented as the percent inhibition of KSHV DNA internalization in comparison with untreated THP-1
cells. B. Effect of endosomal acidiﬁcation inhibitor on KSHV infection of THP-1 cells. THP-1 cells either left untreated (UT) or pre-incubated with NH4Cl (100 mM) for 3 h and
baﬁlomycin (50 nM) for 1 h, incubated with KSHV for 2 h and untreated and treated THP-1 cells were washed to remove uninternalized virus. Cells were incubated in complete
medium for 24 h, RNA was isolated and ORF73 expression was examined as described in Fig. 2B legend. The data are represented as the percent inhibition of KSHV ORF73 gene
expression in comparison with untreated THP-1 cells. C. Role of heparan sulfate and chondroitin sulfate in KSHV binding in primary monocytes. Chondroitin sulfate/heparin
pretreated or untreated KSHV were incubated with 1×105 primary monocytes (ﬁxed with 0.1% paraformaldehyde) at 4 °C for 1 h or heparinase I and III treated (5 and 10 units/ml,
for 2 h at 37 °C) primary monocytes were mildly ﬁxed with 0.1% paraformaldehyde and incubated with KSHV 4 °C for 1 h. The unbound viruses were removed by washing. The cell-
bound virus was quantiﬁed by real-time DNA PCR as described in the Fig. 1C and D legend. Each point represents the average±SD of three experiments. The cell-bound virus in the
presence of chondroitin sulfate/heparin or in the heparinase treated cells was expressed as the percentage of virus binding compared to that of untreated controls. D. KSHV
internalization in primary monocytes upon blocking DC-SIGN. Primary monocytes incubated with mouse IgG or mouse anti-DC-SIGN mAb at 4 °C for 1 h. The washed cells were
incubated with KSHV (10 genome copies/cell) at 4 °C for 1 h followed by at 37 °C for 1 h. Uninternalized virus was removed by washing and trypsinization, internalized viral copy
numbers were determined by real-time DNA PCR as described in the Fig. 1C/D legend. The data are represented as the percent inhibition of KSHV DNA internalization in comparison
with IgG control.
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Depending upon the target cell type, virus infectious pathways can
vary greatly in several aspects such as the choice of receptor, mode of
internalization and nature of virus life cycle. Our current study
uncovers several aspects associated with KSHV infection of mono-
cytes: (a) we demonstrate the role of HS in monocyte infection; (b)
this is ﬁrst study showing KSHV persistence in infected THP-1 for
periods as long as 30 days pi.; (c) our study demonstrates that KSHV's
mode of internalization in monocytic cells differs from HMVEC-d cells
in that the virus utilizes clathrin and caveolin mediated endocytosis
and not macropinocytosis; and (d) endocytosis is followed by the
requirement of low intracellular pH for infection.When one compares
the present study with what is known about KSHV infection in other
target cells, such as adherent HMVEC-d, HUVEC, HFF and dendritic
cells and suspension cells including primary activated human B cells
and monocytes, several similarities and differences emerge which are
summarized and discussed here.
KSHV readily binds THP-1 cells with comparable efﬁciency and
agree with previous studies (Akula et al., 2001b; Dezube et al., 2002;
Raghu et al., 2007) that demonstrated efﬁcient binding of labeledKSHV to a variety of target cells including primary monocytes,
endothelial, epithelial and ﬁbroblast cells. The entry kinetics and
nuclear delivery of viral DNA in THP-1 cells were similar to our earlier
ﬁndings in adherent HMVEC-d, HFF and HUVEC cells (Krishnan et al.,
2004; Raghu et al., 2007, 2009).
Our previous studies in HMVEC-d and HUVEC cells showed the
sustained expression of KSHV latent transcripts and high levels of lytic
switch ORF50 at 2 h p.i. which subsequently declined (Krishnan et al.,
2004; Raghu et al., 2009). Rappocciolo et al. (2006) utilized peripheral
blood CD14+ monocytes to generate mature dendritic cells by
incubating with CD40L. Macrophages were generated by incubating
CD14+ monocytes with 5% heat inactivated, pooled human AB+
serum, and 1000 U/ml recombinant human GM-CSF for 7 days, and
treated overnight with 20 ng/ml human IL-13 (Rappocciolo et al.,
2006). KSHV infection of DCs and macrophages was similar to the
infection of HMVEC-d and HFF cells. They observed the expression of
latent ORF 73 as well as lytic ORF59 and gpK8.1A during 48 h p.i. with
a subsequent nonproductive, latent viral infection without signiﬁcant
viral DNA replication (Rappocciolo et al., 2006).
Our studies also demonstrate that THP-1 cells are susceptible to
primary KSHV infection and support concurrent expression of latent
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expression, we did not observe any sign of KSHV progeny production
as there was no increase in KSHV DNA in infected THP-1 cells. Thus, as
in monocyte derived dendritic cell, KSHV infection of THP-1 cells is
also characterized by a latent viral infection without signiﬁcant viral
DNA replication. However, we also extended the studies by
Rappocciolo et al., and demonstrate that the KSHV genome persisted
in THP-1 cells for the observed 30 days p.i and that the latent KSHV in
THP-1 could be induced with TPA to undergo lytic reactivation to
produce viral progeny. However the number of KSHV genomes
detected in TPA induced cells and cell culture supernatants were less
than 150 and 80/100 ng of DNA respectively. This low genome copy
number is possibly due to relatively lesser number of infected cells at
21 days p.i.
Though the genome copy numbers decreased over time, sustain-
ability of an appreciable amount of KSHV genome up to 30 days
suggests that THP-1 cells could also be used as a model system for
examining the latency program and host factors involved in the
establishment and maintenance of latency. Further studies are
essential to determine how long KSHV infection persists in THP-1
cells and nature of the genome.
Our studies show that KSHV interacts with HS and multiple
integrins for THP-1 cell infection. The importance of HS in KSHV
infection is also shown by Jarousse et al. (2008), who demonstrated
that the low abundance of surface HS is one of the contributing factors
for the reduced susceptibility of B-cell lines to the KSHV infection. The
previous studies in monocytes by Rappocciolo et al. predominantly
examined the role of DC-SIGN in KSHV binding and entry. Role of HS
in KSHV infection of monocytes has not been explored before. We
demonstrated here that KSHV utilizes HS in THP-1 cells and in
primary monocytes as a primary binding receptor to increase the
efﬁciency of infection. This is similar to the use of HS in other target
cells such as HMVEC-d, HFF, HEK-293 and B cells (Akula et al., 2001a,b,
2003; Wang et al., 2001). HS has been shown to be involved in initial
interaction with target cells by several viruses including herpes
simplex virus type 1 and 2 (HSV-1 and HSV-2), cytomegalovirus
(CMV), HIV-1 and human papillomavirus (HPV) (Compton et al.,
1993; Giroglou et al., 2001; Tyagi et al., 2001; WuDunn and Spear,
1989).
DC-SIGN has been shown to play a signiﬁcant role in KSHV binding
to human peripheral blood CD14+ monocyte derived dendritic cells
and macrophages (Rappocciolo et al., 2006). However, in THP-1 cells
blocking DC-SIGN with mannan had no effect on KSHV binding, and
blocking DC-SIGN with mannan and anti-DC-SIGN antibodies inhib-
ited KSHV DNA internalization. Furthermore, entry inhibition by
mannan was only observed at very high mannan concentrations. This
suggests that DC-SIGNmay be playing a role in the post-binding entry
stage of THP-1 cell infection as well as in primary monocytes. We
were not able to observe the role of DC-SIGN at the stage of virus
binding probably due to highly abundant HSmasking the effect of DC-
SIGN. It is well known that virus binding and entry are very distinct
processes involving different receptors. Binding of viruses can occur at
4 °C and entry is an energy dependent phenomenon (blocked by
sodium azide). Viruses can bind to target cells to speciﬁc receptors
and may not enter if the secondary receptors are absent. Initial
interaction with the binding receptor is believed to results in
conformation changes that are required to interact with additional
receptors. We believe that KSHV binding to HS is essential for
subsequent interactions with integrins (as shown by us in HMVEC-d
cells; Veettil et al., 2008) and DC-SIGN in THP-1 cells. Hence, virus still
binds to HS even in the presence of mannan. However, prevention of
subsequent interaction with DC-SIGN by mannan treatment probably
blocks DC-SIGN interactions that plays role in entry.
Our earlier studies have shown that α3β1, αvβ3 and αvβ5
integrins play a role in the post-HS binding stage of KSHV infection of
HMVEC-d, HFF, 293 and Vero cells (Akula et al., 2002; Veettil et al.,2008). Interestingly, KSHV in addition to using the previously
identiﬁed α3β1, αvβ3 and αvβ5 integrins also uses α5β1 integrins
for infection of THP-1 cells. The identity of KSHV envelope
glycoproteins involved in receptor interactions and the role of xCT/
CD98 for THP-1 infection needs to be investigated further.
Herpesviruses and other enveloped viruses enter their target cells
in vitro either by endocytosis or by fusion of their envelope with the
plasma membrane or with the endosomal membrane following
internalization by endocytosis (Hutt-Fletcher, 2007; Nicola et al.,
2003; Nicola and Straus, 2004; Sinzger, 2008). For example, entry of
HSV-1 into Vero and HEp-2 cells is known to occur via fusion at the
plasma membrane (Fuller et al., 1989; Fuller and Spear, 1987).
Whereas CHO-K1 and HeLa cells support a pH-dependent endocytic
route of entry, suggesting HSV enters target cells by more than one
pathway in a cell-speciﬁc manner (Nicola et al., 2003). Similarly EBV
enters primary B cells via endocytosis and human epithelial cells via
fusion at the plasma membrane (Hutt-Fletcher, 2007).
Multiple endocytic pathways operate concurrently at the cell
surface, differing in their mechanism of formation, molecular
machinery involved and cargo destination. The clathrin coated pit
pathway is used for entry by many viruses such as HSV, HIV-1,
inﬂuenza virus, adenovirus and poliovirus (Kalia and Jameel, 2009),
while the caveolar pathway is the main mode of entry for simian virus
40, polyoma virus and echovirus (Anderson et al., 1996; Gilbert and
Benjamin, 2000; Mackay and Consigli, 1976; Pietiainen et al., 2004;
Stang et al., 1997). However, many viruses are also able to utilize
clathrin and caveolin independent pathways, which are less under-
stood in terms of cargo speciﬁcity and molecular machineries
involved. For example, several members of the vaccinia, adeno and
picorna families have been reported to use macropinocytosis, an
endocytic dynamin independent mechanism normally involved in
ﬂuid uptake (Amstutz et al., 2008; Mercer and Helenius, 2008, 2009).
Use of multiple endocytic pathways and receptors for infection of
target cells has been frequently observed in several viruses, while the
use of one pathwaymight predominate over another depending upon
the target cell type. Inﬂuenza virus enters cells predominantly via
clathrin-mediated endocytosis, however the existence of non-clathrin
dependent and non-caveolar dependent endocytic pathways has also
been demonstrated (Sieczkarski and Whittaker, 2002). Similarly,
KSHV utilizes endocytosis as mode of entry to infect HFF, BJAB, HEK
293 and activated primary B cells (Akula et al., 2001b, 2003;
Rappocciolo et al., 2008). However, for infectious entry into
endothelial cells (HMVEC-d and HUVEC), KSHV utilizes an actin
polymerization dependent macropinocytic pathway (Raghu et al.,
2009). In contrast to endothelial cell infection, our observations
suggest that KSHV does not enter THP-1 cells by macropinocytosis.
However, the reduction in KSHV internalization in chlorpromazine
and ﬁlipin pretreated THP-1 cells by 51% and 45% clearly demon-
strates that KSHV entry in these cells involves clathrin and caveolin
dependent endocytic pathways. In addition, when chlorpromazine
and ﬁlipin were used in combination much higher KSHV entry
inhibition (72.3%) was observed suggesting concurrent usage of both
the pathways by KSHV. Supporting this ﬁnding, KSHV has been shown
to induce the TLR3 pathway in THP-1 cells (West and Damania, 2008).
Since TLR3 is sequestered in the endosome and our ﬁnding explains
the possibility that KSHV is being exposed to TLR3 in the endosome
early during the infection. Macropinocytosis appears to play no role in
infection and other modes of entry such as fusion of viral envelope at
the cell membrane cannot be ruled out at the present time.
After endocytic internalization, virus particles are sequestered in
the endosome until proper conditions are met for release of the viral
genome. For many enveloped viruses a low pH in the sorting/late
endosome is the trigger for conformational changes necessary to
initiate membrane fusion events leading to release of the viral
genome at its site of replication. However several other viruses
penetrate the cytosol in a pH independent manner. For example, EBV
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without a requirement for a low pH to penetrate the cytosol (Kock et
al., 1996; Miller and Hutt-Fletcher, 1992). KSHV infection in HFF, HEK
293, HMVEC-d and HUVEC cells is inhibited by preventing endosomal
acidiﬁcation with baﬁlomycin A or NH4Cl (Akula et al., 2003; Raghu et
al., 2009). In agreement with previous studies in other target cells, our
observations in THP-1 show that NH4Cl and baﬁlomycin A1 block
KSHV gene expression, suggesting a requirement for a low pH
intracellular environment for KSHV infection. However, the incom-
plete inhibition of KSHV gene expression also hints at a possibility of
coexistence of pH independent entry portals in THP-1 cells.
Viruses and many other pathogens are known to exploit ligand
mimicry by which they subvert host signaling molecules for their
beneﬁt (Stewart and Nemerow, 2007; Triantaﬁlou et al., 2001). KSHV
interactions withmultiple integrins and associated protein complexes
such as xCT/CD98 in HMVEC-d cells triggers induction of pre-existing
integrin-associated host cell signal pathways, such as FAK, Src, PI3K,
protein kinase C, Rho-GTPases, MEK, ERK1/2, and NF-κB which are
essential for the internalization of viral particles, modulation of actin
cytoskeleton and microtubule polymerization required for cytoplas-
mic trafﬁcking of viral particles, nuclear delivery of viral DNA, and
initiation of viral gene expression (Akula et al., 2002; Naranatt et al.,
2003, 2005; Raghu et al., 2007; Sadagopan et al., 2007; Sharma-Walia
et al., 2005; Veettil et al., 2006). Similar to the adherent HMVEC-d and
HFF cells, KSHV induces host cell FAK, Src, PI3K, ERK1-2 and NF-kB in
THP-1 cells. Inhibition of KSHV entry by tyrosine kinase inhibitors
demonstrates that KSHV infection of THP-1 cells require various
signaling cascades to facilitate its entry and establishment of infection.
Though THP-1 cells are derived from monocytic cells, it is
conceivable that these cells would differ from primary monocytes in
several aspects. However our studies here show that THP-1 cell
infection resembles infection of primary monocytes in the aspects
studied here.We found that similar to THP-1 cells heparan sulfate and
DC-SIGN play signiﬁcant roles in KSHV infection of primary mono-
cytes. Since THP-1 cells can be grown easily compared to primary
monocytes from human peripheral blood, the characterization of
infection described here demonstrates that THP-1 cells can be
exploited as a good model to study KSHV infection of monocytes,
particularly themode of infection, receptors, role of host cell signals in
infection, cytokine induction, latency and host factors involved in the
establishment and maintenance of latency.
Materials and methods
Cell lines and viruses
THP-1 cells from the American Type Culture Collection (Manassas,
VA) and KSHV carrying BCBL-1 cells grown in RPMI 1640 medium
(Gibco BRL, Grand Island, NY) containing 10% fetal calf serum
(HyClone, Logan, UT), 25 mM HEPES and antibiotics were maintained
at 37 °C in 5% CO2 atmosphere. Puriﬁed KSHV preparations used in the
study were produced by inducing KSHV lytic cycle from BCBL1-1 cells
as described previously (Krishnan et al., 2004; Naranatt et al., 2002,
2003, 2004, 2005; Raghu et al., 2007; Sharma-Walia et al., 2005).
Brieﬂy, KSHV lytic cycle was induced in BCBL-1 cells by treatment
with TPA (20 ng/ml) for 5 days. The cells were then centrifuged, and
the supernatant was collected. The supernatants were centrifuged at
14,000 rpm for 2 h at 4 °C to pellet the virus. The viral pellets were
resuspended, centrifuged at low speed several times to remove cell
debris and ﬁltered through 0.45 μ. The resulting supernatant was then
centrifuged at 30,000 rpm, for 2 h at 4 °C. The viral pellet was
resuspended in serum free DMEM. KSHV DNA was extracted from the
virus, and copy numbers were quantitated by real-time DNA PCR
using primers amplifying the KSHV ORF73 gene as described
previously (Krishnan et al., 2004; Naranatt et al., 2005; Raghu et al.,
2007; Sharma-Walia et al., 2005; Veettil et al., 2008). RadiolabeledKSHV was prepared as described previously (Akula et al., 2001a,b,
2002).
Blood donors
Blood from healthy donors was used in this study for purifying
CD14+ monocytes. Informed consent was obtained according to
Rosalind Franklin University Institutional Review Board guidelines.
Preparation of primary monocytes from blood
The peripheral blood mononuclear cell (PBMC) fractions were
collected from the heparinized blood by differential density centrifu-
gation over Ficoll-Paque PLUS (GE Healthcare, Piscataway, NJ). After
washing cells twice in Hank's balanced salt solution, monocytes were
puriﬁed from the PBMC via magnetic separation using beads coated
with anti-CD14 antibody following the manufacturer's instructions
(Miltenyi Biotec, Germany). The purity of the fractionated primary
monocytes, as determined by ﬂow cytometric analysis with FITC
conjugated anti-CD14 antibody, was N95%. Puriﬁed CD14+monocytes
were used immediately for the KSHV binding and entry studies.
Antibodies and reagents
Heparin, chondroitin sulfate, mannan, chlorpromazine, cytochala-
sin D, EIPA (5-N-ethyl-N-isoproamiloride), ﬁlipin, NH4Cl, genistein,
tyrphostin 1 (protein tyrosine kinase inhibitors), heparinase I,
heparinase III were obtained from Sigma, St Louis, MO. Paraformal-
dehyde was from Electron Microscopy Sciences, Hatﬁeld, PA. Mouse
anti-DC-SIGN mAb (clone 120507) was from R&D Systems, Minnea-
polis, MN. FITC conjugated anti-CD14 antibody was from eBioscience,
San Diego, CA. Mouse anti-pY397 FAK, mouse anti-total FAK and anti-
total PI3K antibodies were obtained from BD Biosciences, San Jose, CA.
Anti-phospho-Src (PY418), anti-total Src and anti-phosphotyrosine
(PY20) antibodies were obtained from Upstate Biotechnology, Lake
Placid, NY. Rabbit antibodies detecting the phosphorylated forms of
ERK1/2 (Thr 202/Tyr 204 phospho-p44/42 mitogen-activated pro-
tein kinase [MAPK]), mouse anti phospho-p65 and total p65, were
obtained from Cell Signaling Technology, Beverly, MA. Total ERK2
antibody was from Santa Cruz Biotechnology Inc., Santa Cruz, CA.
Mouse monoclonal anti-KSHV gpK8.1A antibodies (4A4) have been
described before (Zhu et al., 1999). Rat monoclonal anti-LANA-1
antibodywas obtained fromAdvanced Biotechnologies Inc., Columbia,
MD. Anti-rabbit and anti-mouse horseradish peroxidase linked
antibodies were from Kirkegaard and Perry Laboratories, Inc.,
Gaithersberg, MD. Secondary antibodies for immunoﬂuorescence
were purchased from Molecular Probes-Invitrogen Corp., Carlsbad,
CA. Rabbit anti-integrinα3 and β1 and soluble human integrinsα3β1,
αvβ3, αvβ5 and α5β1 were from Upstate Biotechnology, Lake Placid,
NY. Recombinant human integrin α4β7 was from R&D Systems,
Minneapolis, MN.
Radiolabeled KSHV binding assay
THP-1 cells (1×106) were washed and mildly ﬁxed with 0.1%
paraformaldehyde. The ﬁxed cells were further washed twice with
RPMI containing 5% FBS and incubated with [3H] labeled KSHV for 1 h
at 4 °C. After incubation, the cells were washed ﬁve times and lysed
and the radioactive virus was precipitated with trichloroacetic acid
and counted in a scintillation counter (Akula et al., 2001a,b, 2002).
Heparinase treatment
For enzymatic removal of cell surface heparan sulfate, THP-1 cells
and primary monocytes were incubated with serum free DMEM
containing heparinase I and III (5 and 10 units/ml) or DMEM alone for
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the KSHV binding studies as described below.
Virus binding assay using non-radioactive/unlabeled KSHV
Untreated or heparinase I and III treated THP-1 cells/primary
monocytes were washed and mildly ﬁxed with 0.1% paraformalde-
hyde. The ﬁxed cells were further washed twice with RPMI containing
5% FBS and incubated with KSHV for 1 h at 4 °C. After incubation,
unbound KSHVwere removed by washing and DNAwas isolated from
the cells. Cell-bound KSHVwere quantitated by real-time DNA PCR for
ORF73 as described previously (Naranatt et al., 2005; Raghu et al.,
2007).
Cytotoxicity assays
THP-1 cells were incubated with RPMI 1640 medium containing
different concentrations of various inhibitors and cellular toxicity by
using an MTT assay kit (ATCC) in accordance with the manufacturer's
recommendations.
Preparation of DNA and RNA
Isolation of total DNA from the viral stocks and infected or
uninfected THP-1 cells by a DNeasy tissue kit (QIAGEN, Inc., Valencia,
CA) and isolation of total RNA from infected or uninfected cells using
an RNeasy kit (QIAGEN) were carried out as described previously
(Krishnan et al., 2004, 2005; Raghu et al., 2007).
Measurement of KSHV DNA internalization and nuclear delivery
THP-1 cells were infected with 10 DNA copies per cell of KSHV for
different time points or for 2 h with 10–40 DNA copies per cell. After
incubation with virus, cells were washed twice with PBS to remove
unbound virus. Cells were treated with 0.25% trypsin–EDTA for 5 min
at 37 °C to remove the bound, non-internalized virus and washed
twice more to remove the virus and trypsin–EDTA. Total DNA isolated
from cells or from nuclear fractions was tested by real-time DNA PCR
for ORF73 as described previously (Naranatt et al., 2005; Raghu et al.,
2007). For examining the role of DC-SIGN in KSHV internalization,
THP-1 cells were pre-incubated with different concentrations of
mannan, infected with 10 DNA copies per cell and KSHV DNA
internalization was examined as described above. To examine KSHV
internalization after blocking DC-SIGN, THP-1 cells and primary
monocytes were pre-incubated with mouse anti-DC-SIGN mAb or
mouse IgG (15 μg/ml) for 1 h at 4 °C. The antibody pre-incubated cells
were then incubated with KSHV (10 genome copies/cell) at 4 °C for
1 h followed by at 37 °C for 1 h and KSHV DNA internalization was
examined as described above. To examine the role of heparan sulfate
in KSHV internalization, KSHV pre-incubated with different concen-
trations of heparin (25 μg, 50 μg, 100 μg and 150 μg/ml) for 1 h at
37 °C were incubated with THP-1 for 2 h and KSHV DNA internaliza-
tion was determined as described above.
For determining the role of signal induction in KSHV entry, THP-1
cells were pre-incubated with Tyrphostin I (50 μM and 100 μM) and
genistein (50 μM and 100 μM) for 1 h at 37 °C. Untreated and treated
cells were infected with KSHV (10 DNA copies/cell) for 2 h and
internalized KSHV copies were determined by real-time DNA PCR as
described above. To determine the mode of KSHV entry, THP-1 cells
were pre-incubated (1 h at 37 °C) with chlorpromazine (1.5 μg/ml),
ﬁlipin (2.5 μg/ml), EIPA (1.5 μg/ml), cytochalasin D (2.5 μg/ml) as
well as with combination of chlorpromazine (1.5 μg/ml) and ﬁlipin
(2.5 μg/ml) and infected with KSHV (10 DNA copies/cell) and KSHV
internalization was determined as described above.Examination of KSHV gene expression by real-time reverse transcription
(RT)-PCR
THP-1 cells ()1×106 infected with 30 DNA copies per cell of KSHV
for different time points (2 h, 8 h, 24 and 48 h p.i) were washed three
times with 1× PBS to remove the unbound virus and lysed with RLT
buffer (QIAGEN). Total RNAwas isolated from the lysate using RNeasy
kits (QIAGEN) according to the manufacturer's protocols and
quantiﬁed spectrophotometrically. The abundance of ORF 50 and
ORF 73 transcripts was detected by real-time rRT-PCR using speciﬁc
real-time primers and TaqMan probes as described previously
(Krishnan et al., 2004; Sharma-Walia et al., 2005). The expression
levels of the viral transcripts were normalized to 18s rRNA gene
expression. Possibility of false signal from trace amounts of viral DNA
was ruled out by including control reactions with RNase treated
samples and reactions without rTth DNA polymerase enzyme.
For examining the role of integrins in establishment of KSHV gene
expression, THP-1 cells were infected with 30 DNA copies per cell of
KSHV that were pretreated with 10 μg/ml of human soluble integrins
( α3β1, αvβ3, αvβ5, α5β1 and α4β7) and expression of ORF73 was
determined at 24 h p.i. as described above. For examining the
requirement of endosomal acidiﬁcation for KSHV infection, THP-1
cells were pre-incubated with 100 mM NH4Cl for 3 h or 50 nM
baﬁlomycin A for 1 h, followed by incubation with KSHV (30 DNA
copies/cell) for 2 h. Untreated and treated cells were washed,
trypsinized to remove uninternalized KSHV and then ORF73 gene
expression was examined at 24 h p.i.
KSHV DNA nuclear delivery assay
THP-1 cells infected with KSHV were collected at different time
points, washed, and treated with trypsin–EDTA (0.25% trypsin and
5 mM EDTA) to remove uninternalized virus. Nuclear fractions were
prepared from infected and uninfected THP-1 cells using a Nuclei EZ
isolation kit (Sigma) following the manufacturer's recommendations.
The purity of nuclear preparations was assessed by immunoblotting
using anti-lamin B and anti-tubulin antibodies. DNA isolated from
infected cell nuclei were used for determining the nuclear delivery of
KSHV genome by real-time DNA PCR as described previously
(Naranatt et al., 2005; Raghu et al., 2007).
Immunoﬂuorescence assay (IFA)
THP-1 cells were infected with 30 DNA copes per cell of KSHV for
2 h. Mock infected and infected cells were washed, treated with 0.5%
trypsin to remove uninternalized KSHV, and incubated in complete
growth media for different time points (8 h, 24 h and 48 h p.i.). Cells
were washed, ﬁxed with 2% paraformaldehyde on a glass slide,
permeabilized with 0.2% Triton X-100, blocked with Image-iT™ FX
signal enhancer (Invitrogen) for 20 min and then incubated with rat
anti-KSHV ORF73 (1:100) and mouse anti-gpK8.1 antibodies. Cells
were washed with PBS, incubated with anti-rat Alexa Fluor 488
antibodies (1:1000) and anti-mouse Alexa Fluor 594 antibodies
(1:2000), respectively, for 1 h at RT. The cells were washed, mounted
with antifade reagent containing DAPI (4',6'-diamidino-2-phenylin-
dole) and visualized under a Nikon ﬂuorescent eclipse 80i microscope.
Images were processed using Metamorph imaging software. DC-SIGN
staining in uninfected THP-1 cells was done as described above using
mouse anti-DC-SIGN mAb and goat ant-mouse Alexa Flour 488
secondary antibody.
Laser-scanning confocal immunoﬂuorescence
THP-1 cells infected with 10 DNA copies per cell of KSHV were
ﬁxed for 10 min with 2% paraformaldehyde, permeabilized with 0.2%
Triton X-100 for 5 min, washed and blockedwith Image-iT™ FX signal
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incubated with rabbit anti-KSHV gB antibody or mouse anti-integrin
antibodies followed by goat anti-rabbit Alexa Fluor 488 and goat anti-
mouse Alexa Fluor 594-labeled antibody. The Olympus Fluoview 300
ﬂuorescence confocal microscope was used for imaging and analysis
was performed using Fluoview software (Olympus, Melville, NY).
Western blot analysis
Infected and uninfected cells were lysed in RIPA lysis buffer
containing a protease inhibitor cocktail. Cellular debris was removed
by centrifugation at 13,000 × g for 20 min at 4 °C. The protein
concentration of the clariﬁed supernatant was determined with a
micro-bicinchoninic acid protein assay kit (Pierce, Rockford, IL). Each
sample was heated at 95 °C for 5 min, resolved by 10% SDS-PAGE, and
transferred to a nitrocellulose membrane. Phosphorylated FAK, Src,
NF-κB and ERK1/2 were assessed by immunoblotting with speciﬁc
antibodies. To conﬁrm equal protein loading, membranes were
stripped and reprobed with anti-total FAK, Src, NF-κB and ERK1/2
antibodies. Horseradish peroxidase-conjugated secondary antibodies
were used for detection. Immunoreactive bands were developed by
enhanced chemiluminescence reaction (NEN Life Sciences Products,
Boston, MA) and quantiﬁed by following standard protocols (Sharma-
Walia et al., 2004). To examine phosphorylated PI3K, THP-1cells
infected with KSHV (20 DNA copies/cells) for different times at 37 °C
were washed, lysed in RIPA lysis buffer, clariﬁed by centrifugation for
15 min at 4 °C and normalized to equal amounts of total protein. The
lysate was incubated for 2 h with anti-total PI3K antibody at 4 °C, and
immune complexeswere captured using 10 μl of protein G-Sepharose.
Theywerewashed three timeswith RIPA lysis buffer, boiledwith SDS-
PAGE sample buffer, and run on a 10% SDS-PAGE gel. The
phosphorylated PI3K was detected by immunoblotting with mouse
anti-phosphotyrosine (PY20) antibody. To conﬁrm equal protein
loading, membranes were stripped and reprobed with anti-total PI3K
antibodies.
Flow cytometry
THP-1 cells for ﬂuorescence-activated cell sorting (FACS) analysis
were prepared following manufacturer's guidelines (BD Biosciences).
DC-SIGN staining was performed using anti-DC-SIGN mAb. The data
were collected using FACSCalibur ﬂow cytometer (Becton Dickinson)
and analyzed with CellQuest Pro software (Becton Dickinson) at the
Rosalind Franklin University of Medicine and Science ﬂow cytometry
core facility.
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